-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, Dhvj41XOw4wZh8uPwHbl1gp2jiqEpvkFxRplZF8UCMyVKynXouJTCvS1Pk8cLkYB iC9rmIT2NlhqUrr4L0X3Ug== /in/edgar/work/20000628/0000912057-00-030260/0000912057-00-030260.txt : 20000920 0000912057-00-030260.hdr.sgml : 20000920 ACCESSION NUMBER: 0000912057-00-030260 CONFORMED SUBMISSION TYPE: 424B5 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000628 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOME THERAPEUTICS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: [2835 ] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 424B5 SEC ACT: SEC FILE NUMBER: 333-32614 FILM NUMBER: 663777 BUSINESS ADDRESS: STREET 1: 1OO BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 424B5 1 a424b5.txt FORM 424B5 FILED PURSUANT TO RULE 424(B)(5) FILE NO. 333-32614 PRICING SUPPLEMENT NO. 2 DATED JUNE 28, 2000 (TO PROSPECTUS DATED JUNE 21, 2000). 395,000 SHARES GENOME THERAPEUTICS CORP. COMMON STOCK ------------------------ On June 26, 2000, we sold 145,000 shares of our common stock, par value $0.10 per share (the "Common Stock"), at a weighted average price of $32.5841 per share. On June 28, 2000, we sold 250,000 shares of Common Stock at a weighted average price of $30.84 per share. Each of these sales was conducted through our agent, Tucker Anthony Incorporated, in transactions effected through the Nasdaq National Market. Gross Proceeds to Genome Therapeutics Corp.................. $12,434,694.50 Commission to Tucker Anthony................................ $ 310,925.00 Net Proceeds to Genome Therapeutics Corp.................... $12,123,769.50 On June 28, 2000 the last reported sales price of the Common Stock on the Nasdaq National Market was................... $ 30.75
------------------------ Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. -----END PRIVACY-ENHANCED MESSAGE-----